Mylimus 0.5 Capsule
By Mylimus
Rx
10 Capsule in a Strip

Composition
Tacrolimus(0.5mg)

Manufacturer - Mylan Pharmaceuticals Pvt Ltd
Mylan Pharmaceuticals Private Limited , Commercial Operations , Prestige Tech Park,Platina-3, 7th to 12th floor, Prestige Tech Park, Kadubesanahalli, Bangalore -560103

Expires on or after
May, 2026

liver
When considering Mylimus 0.5 Capsule, it is important to be cautious if you have liver disease. Patients with liver conditions may require adjustment of the Mylimus 0.5 Capsule dosage. For individuals with liver diseases or conditions, it is strongly recommended to consult with a healthcare provider before initiating the use of Mylimus 0.5 Capsule.

kidney
Mylimus 0.5 Capsule requires caution in kidney disease patients. Adjusting the dose may be necessary. Consult your doctor, especially if you have kidney conditions, before using Mylimus 0.5 Capsule.

alcohol
To ensure safety while taking Mylimus 0.5 Capsule, it is important to avoid alcohol consumption. Mixing alcohol with this medication can lead to increased risk of adverse effects. It is advisable to consult your doctor before drinking alcohol while using Mylimus 0.5 Capsule.

driving
Mylimus 0.5 Capsule can reduce alertness, impact vision, and induce drowsiness or dizziness. Avoid driving if you experience these effects. Vision issues or nervous disturbances may occur in some individuals, so refrain from driving if such symptoms arise post-taking Tacrol 0.5 mg Capsule 10's.

pregnancy
Mylimus 0.5 Capsule may not be safe during pregnancy. Animal studies suggest potential harm to the developing baby. Consult your doctor for a thorough evaluation of benefits and risks before using this medication. If pregnant, be aware of possible kidney or neonatal hyperkalemia risks. Utilize effective contraception while taking Mylimus 0.5 Capsule.

breastfeeding
Mylimus 0.5 Capsule may not be safe for breastfeeding as it can pass into breastmilk, potentially harming the baby. Inform your doctor if you are breastfeeding before taking this medication. It is advisable to avoid breastfeeding while using Mylimus 0.5 Capsule.
Habit Forming | No |
Chemical Class | Macrolide Lactams |
Therapeutic Class | - |
Action Class | Immunosuppressant- Calcineurin inhibitors |
₹206.42
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024